🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the companies withheld alleged dangers that the medication created to children's brain development.

The court filing follows a month after President Donald Trump advocated an unverified association between using acetaminophen - referred to as acetaminophen - throughout gestation and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he claimed they "deceived the public by gaining financially from suffering and promoting medication regardless of the potential hazards."

The manufacturer states there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its website, Kenvue also said it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a verified association between using acetaminophen and autism spectrum disorder."

Organizations acting on behalf of medical professionals and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to manage discomfort and elevated temperature, which can pose serious health risks if not addressed.

"In more than two decades of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of acetaminophen in any period of gestation leads to neurodevelopmental disorders in young ones," the group said.

The court filing cites current declarations from the previous government in arguing the drug is reportedly hazardous.

Last month, the former president caused concern from health experts when he advised women during pregnancy to "fight like hell" not to consume acetaminophen when sick.

Federal regulators then released a statement that medical professionals should consider limiting the use of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had vowed in spring to undertake "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But authorities advised that identifying a unique factor of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and disability that affects how individuals perceive and relate to the surroundings, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is running for the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around paracetamol and autism spectrum disorder.

The case attempts to require the corporations "destroy any marketing or advertising" that states acetaminophen is secure for expectant mothers.

The Texas lawsuit mirrors the grievances of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in two years ago.

A federal judge rejected the lawsuit, stating investigations from the family's specialists was inconclusive.